PMCH and schizophrenia: An interaction between vitamin D and the melanotropin system during development has been demonstrated by Eyles et al. (2007) who found that prenatal vitamin D deficiency in rodents leads to elevations in the functional antagonist of alpha-MSH, the melanotropic peptide MCH. However, McGrath and colleagues have also shown that the relationship between vitamin D in gestation and subsequent schizophrenia may be complex, in that those with low maternal vitamin D are at increased risk of bearing offspring who become schizophrenic as are those with overly high vitamin D (McGrath et al., 2010a).